CClinicalTrials.gg
Not yet recruitingNCT06233643Updated Jan 31, 2024

The Efficiency of Acupuncture Combined Intradermal Sterile Water Application in Acute Renal Colic

An interventional study of Phloroglucinol and Acupuncture Combined Intradermal Sterile Water in Renal Colic, sponsored by The Third Affiliated Hospital of Beijing University of Chinese Medicine. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-01-31.

Sponsored by The Third Affiliated Hospital of Beijing University of Chinese Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the analgesic effect and tolerance profile of acupuncture combined with intradermal sterile water application versus intramuscular phloroglucinol in acute renal colic. In this study, we aimed primarily to test the efficacy of acupuncture combined with intradermal sterile water application as a rapid and effective treatment in severe renal colic.

Participants will randomly divided into two groups. The first group received only intramuscular phloroglucinol, the second group received acupuncture and intradermal sterile water.The visual analog scale (VAS,ranging from 0 for no pain to 10 for maximum imaginable pain) was used to assess pain intensity at baseline and at 10, 20, 30, 45,and 60 minutes following the start of the treatment protocol. Possible treatment side effects were also recorded.

Read the detailed description

Inclusion criteria:We included all consecutive patients aged >18 years and presenting to our medical center with uncomplicated acute renal colic. Renal colic was considered if the patient description of pain included sudden onset of symptoms; unilateral flank or lower abdomen pain; irradiation to the back, side, or groin region; urination problems, including urinating difficultly and/or an abnormally dark or red urine; and the absence of other obvious conditions explaining patient symptoms.

Exclusion criteria:We excluded patients with complicated acute renal colic, defined by the presence of bilateral pain, fever, and/or decreased urine output (\<500 mL per day). Patients presenting with posttraumatic pain, those taking anticoagulant medications or with coagulation problems, those with skin afflictions (infections, hematoma, dermatosis) that would impair the use of certain acupuncture points, those unable to assess the degree of pain using the VAS, those who had received analgesics in the 6 hours prior to enrollment, those refusing or unable to give written consent, and pregnant women were also excluded from this study. All participants read and signed the informed consent form of the study, which was approved by the ethics committee of the Third Affiliated Hospital of Beijing University of Chinese Medicine.

02

Conditions studied

  • Renal Colic

Keywords

  • Acupuncture
  • Intradermal Sterile Water
  • NSAIDS
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria:We included all consecutive patients aged >18 years and presenting to our medical center with uncomplicated acute renal colic. Renal colic was considered if the patient description of pain included sudden onset of symptoms; unilateral flank or lower abdomen pain; irradiation to the back, side, or groin region; urination problems, including urinating difficultly and/or an abnormally dark or red urine; and the absence of other obvious conditions explaining patient symptoms.

Exclusion criteria:We excluded patients with complicated acute renal colic, defined by the presence of bilateral pain, fever, and/or decreased urine output (\<500 mL per day). Patients presenting with posttraumatic pain, those taking anticoagulant medications or with coagulation problems, those with skin afflictions (infections, hematoma, dermatosis) that would impair the use of certain acupuncture points, those unable to assess the degree of pain using the VAS, those who had received analgesics in the 6 hours prior to enrollment, those refusing or unable to give written consent, and pregnant women were also excluded from this study. All participants read and signed the informed consent form of the study, which was approved by the ethics committee of the Third Affiliated Hospital of Beijing University of Chinese Medicine.

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    The group received acupuncture combined with intradermal sterile water

    These acute renal colic patients who will received acupuncture combined with intradermal sterile water

    Combination Product: Acupuncture Combined Intradermal Sterile Water

  • Active comparator
    The group received intramuscular inject phloroglucinol

    These acute renal colic patients who will received intramuscular inject phloroglucinol.

    Drug: Phloroglucinol

Interventions

  • DrugPhloroglucinol

    The active comparators will be treated with 40 mg of Phloroglucinol in the form of a single intramuscular injection.

  • Combination productAcupuncture Combined Intradermal Sterile Water

    Acupuncture was applied to a seated patient using the urinary bladder meridian points and combianed Intradermal Sterile Water in costovertebral area where the patient's pain was located (Sterile water of 0.5 ml was injected as intradermal into 4 points at a depth of 1-3 mm to form papules)

05

What researchers measure

Primary outcomes

  1. Baseline characteristics of patients

    Baseline characteristics of patients between two groups concerning age (years), sex (male or female ), and baseline VAS score (ranging from 0 for no pain to 10 for maximum imaginable pain)

    Time frame: before treatment

  2. primary outcome

    Visual analogue scale (VAS, ranging from 0 for no pain to 10 for maximum imaginable pain) will be used to assess pain intensity after 10, 30, 60, and 120 minutes.

    Time frame: 10, 30, 60, and 120 minutes after treatment.

Secondary outcomes

  1. side effects

    Document any side effects that occur after the intervention

    Time frame: in 120 minutes after treatment.

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT06233643
Lead sponsor
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Responsible party
Jianghua Yang (Urologist of Third BUCM,MD, The Third Affiliated Hospital of Beijing University of Chinese Medicine) — Principal investigator
First posted
Jan 31, 2024
Start date
Feb 1, 2024 (estimated)
Primary completion
Feb 1, 2024 (estimated)
Completion
Jan 31, 2025 (estimated)
Last update
Jan 31, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion